載入...
Double blind trial of recombinant human erythropoietin in preterm infants.
Twenty four infants between 27 and 33 weeks' gestation were recruited into a double blind study to investigate the use of recombinant human erythropoietin (r-HuEpo) for the prevention of anaemia of prematurity. Between 50 and 150 U of r-HuEpo (n = 16) or placebo was administered subcutaneously...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
1993
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1590386/ https://ncbi.nlm.nih.gov/pubmed/8466265 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|